EMILY BOWER: Open Payments
NPI 1730705039 · CAMDEN, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$170 in 3 payments from 3 companies in 2025. Trend: 2023 $91 · 2024 $79 · 2025 $170
Food & beverage: $170
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 1 | $125 |
| Ipsen Biopharmaceuticals, Inc | 1 | $26 |
| Madrigal Pharmaceuticals | 1 | $19 |
Products named: IQIRVO, REZDIFFRA.
Industry payments across NJ — which companies pay providers there.
